5,783 followers
New Research: Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203N https://t.co/RWq6aoExlQ #pharmacology
New Research: Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203N https://t.co/RWq6aoExlQ #pharmacology